Emotional modulation of pain and spinal nociception in persons with major depressive disorder (MDD)

被引:33
|
作者
Terry, Ellen L. [1 ]
DelVentura, Jennifer L. [1 ]
Bartley, Emily J. [1 ]
Vincent, Ashley L. [1 ]
Rhudy, Jamie L. [1 ]
机构
[1] Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA
关键词
Affective processing; Major depressive disorder; Pain modulation; Psychophysiology; RIII reflex; Supraspinal processing; FLEXION REFLEX NFR; AFFECTIVE STARTLE MODULATION; HEALTH SURVEY SF-36; PERCEPTION; BRAIN; MOTIVATION; SENSITIZATION; STIMULATION; THRESHOLD; PICTURES;
D O I
10.1016/j.pain.2013.08.009
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Major depressive disorder (MDD) is associated with risk for chronic pain, but the mechanisms contributing to the MDD and pain relationship are unclear. To examine whether disrupted emotional modulation of pain might contribute, this study assessed emotional processing and emotional modulation of pain in healthy controls and unmedicated persons with MDD (14 MDD, 14 controls). Emotionally charged pictures (erotica, neutral, mutilation) were presented in 4 blocks. Two blocks assessed physiological-emotional reactions (pleasure/arousal ratings, corrugator electromyography (EMG), startle modulation, skin conductance) in the absence of pain and 2 blocks assessed emotional modulation of pain and the nociceptive flexion reflex (NFR, a physiological measure of spinal nociception) evoked by suprathreshold electric stimulations. Results indicated pictures generally evoked the intended emotional responses; erotic pictures elicited pleasure, subjective arousal, and smaller startle magnitudes, whereas mutilation pictures elicited displeasure, corrugator EMG activation, and subjective/physiological arousal. However, emotional processing was partially disrupted in MDD, as evidenced by a blunted pleasure response to erotica and a failure to modulate startle according to a valence linear trend. Furthermore, emotional modulation of pain was observed in controls but not MDD, even though there were no group differences in NFR threshold or emotional modulation of NFR. Together, these results suggest supraspinal processes associated with emotion processing and emotional modulation of pain may be disrupted in MDD, but brain to spinal cord processes that modulate spinal nociception are intact. Thus, emotional modulation of pain deficits may be a phenotypic marker for future pain risk in MDD. (C) 2013 International Association for the Study of Pain. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:2759 / 2768
页数:10
相关论文
共 50 条
  • [31] Results of a whole genome association study for Major Depressive Disorder (MDD)
    Sakul, Hakan
    Hinds, David A.
    Frazer, Kelly A.
    Cox, David R.
    Hyde, Craig
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2006, 141B (07) : 693 - 693
  • [32] The neurocognitive profile of post-traumatic stress disorder (PTSD), major depressive disorder (MDD), and PTSD with comorbid MDD
    Koopowitz, Sheri-Michelle
    Mare, Karen Thea
    Zar, Heather J.
    Stein, Dan J.
    Ipser, Jonathan C.
    [J]. BRAIN AND BEHAVIOR, 2021, 11 (04):
  • [33] Superiority of Escitalopram over Paroxetine in the treatment of Major Depressive Disorder (MDD)
    Kasper, S.
    Baldwin, D.
    Boulenger, J. P.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 337 - 337
  • [34] Amygdala Volume Is Associated with Helplessness in Adults with Major Depressive Disorder (MDD)
    Buchholz, Jennifer L.
    Rosso, Isabelle M.
    Killgore, William D. S.
    Fukunaga, Rena
    Olson, Elizabeth A.
    Demers, Lauren A.
    Rauch, Scott L.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (09) : 65S - 65S
  • [35] Response to D-amphetamine is altered in major depressive disorder (MDD).
    Tremblay, LK
    Busto, U
    Naranjo, CA
    Cardenas, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 130 - 130
  • [36] Volume of the midbrain dorsal raphe nucleus in major depressive disorder (MDD)
    Stockmeier, CA
    Saenz, MD
    Smith, E
    Miguel-Hidalgo, JJ
    Friedman, L
    Rajkowska, G
    [J]. BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 183S - 183S
  • [37] Blunted d-amphetamine response in major depressive disorder (MDD).
    Tremblay, LK
    Naranjo, CA
    Busto, U
    Cardenas, L
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 65 (02) : 141 - 141
  • [38] Adjunctive aripiprazole in major depressive disorder (MDD): efficacy and predictors of remission
    Nelson, J. C.
    Thase, M. E.
    Baker, R. A.
    Rollin, L. M.
    McQuade, R. D.
    Marcus, R. N.
    Berman, R. M.
    Wisniewski, S. R.
    Gismondi, R.
    Loze, J. Y.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S386 - S386
  • [39] Efficacy and safety of sertraline in the treatment of pediatric major depressive disorder (MDD)
    Wagner, K
    Donnelly, C
    Wohlberg, C
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S231 - S232
  • [40] ECONOMIC ANALYSIS OF ESCITALOPRAM (GENERIC DRUG) IN MAJOR DEPRESSIVE DISORDER (MDD)
    Walczak, J.
    Nogas, G.
    Garbacka, M.
    Obrzut, G.
    Pieniazek, I
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A114 - A114